Treatment of chromoblastomycosis with terbinafine: Experience with four cases

@article{Bonifaz2005TreatmentOC,
  title={Treatment of chromoblastomycosis with terbinafine: Experience with four cases},
  author={Alexandro Bonifaz and Amado Sa{\'u}l and Vanessa Paredes-Sol{\'i}s and Javier Araiza and Leonel el Fierro-Arias},
  journal={Journal of Dermatological Treatment},
  year={2005},
  volume={16},
  pages={47 - 51}
}
Background: Chromoblastomycosis is a chronic subcutaneous mycosis that occurs more frequently in tropical and subtropical areas and is caused by a group of dematiaceous fungi. It is a difficult‐to‐treat mycosis with low cure rates and a high rate of relapses. Objective: The objective of this trial is to prove the efficacy and tolerance of oral terbinafine in four cases of chromoblastomycosis. Methods and results: We included four cases of chromoblastomycosis, proved clinically and mycologically… 
Chromoblastomycosis: still a therapeutic challenge
TLDR
Oral itraconazole and terbinafine have both presented results consistent enough to be considered as ‘methods of choice’, but therapy still poses a great challenge.
Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
TLDR
There is no treatment of choice for this neglected mycosis, but rather several treatment options, and treatment should be guided according to clinical, mycological and histopathological criteria.
Treatment of chromoblastomycosis with a combination of debulking surgery, intralesional amphotericin B, and oral terbinafine
  • R. Ranawaka
  • Medicine
    International journal of dermatology
  • 2021
TLDR
Treatment of chromoblastomycosis with a combination of debulking surgery, intralesional amphotericin B, and oral terbinafine in an elderly farmer with a 12-year history of a verrucous and hyperkeratotic plaque on the right foot with foul-smelling discharge and associated lymphedema of the leg.
Chromoblastomycosis Due to Fonsecaea monophora in a Man with Nephritic Syndrome
TLDR
It is believed that combination therapy with itraconazole and terbinafine would be a suitable option for infections caused by F. monophora in an immunosuppressed patient after the patient demonstrated marked improvement after receiving appropriate antifungal therapy for 3 months.
CHROMOBLASTOMYCOSIS MASQUERADING AS DERMATOPHYTOSIS, WITH THE DESCRIPTION OF A NEW OPPORTUNISTIC SPECIES.
TLDR
The case was unusual in its clinical presentation and this is the first case of chromoblastomycosis reported to be caused by a new opportunistic species of the genus Rhinocladiella, which originally was a saprophytic dematiaceous fungus recovered from maize field soil from Colombia.
Histopathology and antifungal treatment of experimental murine chromoblastomycosis caused by Cladophialophora carrionii.
TLDR
This study suggests that the newer triazoles have potential in the treatment of chromoblastomycosis caused by C. carrionii, with posaconazole being the only drug that reduced the initial lesion size, while voriconazole and terbinafine reduced growth relative to controls.
USE OF AMPHOTERICIN B IN THE SIMULTANEOUS TREATMENT OF CHROMOBLASTOMYCOSIS AND AMERICAN TEGUMENTARY LEISHMANIASIS: A CASE REPORT
TLDR
It was observed that the patient had an important improvement of the CMB lesions with the use of amphotericin B in combination with itraconazole, thus demonstrating the role that the former can play in the therapy of this fungal disease.
Challenges in the Therapy of Chromoblastomycosis
TLDR
The most used therapeutic options against CBM are reviewed as well as the several factors that may have impact on the patient’s outcome.
...
...

References

SHOWING 1-10 OF 38 REFERENCES
ITRACONAZOLE IN THE TREAMENT OF CHROMOBLASTOMYCOSIS DUE TO FONSECAEA PEDROSOI
TLDR
The results support those of previous trials, suggesting that itraconazole is an effective compound against chromoblastomycosis due to Fonsecaea pedrosoi.
Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study
TLDR
For the first time with this disease, total cure was observed even in imidazole‐refractory patients or chronic cases (47·2% with a lesion present for longer than 10 years); the efficacy of terbinafine in Cladosporium carnonii‐infected patients seemed higher, as indicated by the examination at 4 months.
Treating chromoblastomycosis with systemic antifungals
TLDR
In extensive and refractory cases, chemotherapy with oral antifungals may be associated with thermotherapy (local heat and/or cryosurgery) and limited or early cases may be managed with surgical methods, always associated with oralantifungal agents.
Treatment of tropical mycoses.
  • Á. Restrepo
  • Medicine, Biology
    Journal of the American Academy of Dermatology
  • 1994
Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil.
TLDR
The combination therapy was considered effective in treating the poorly responsive chromoblastomycosis of all four patients and some success with alternative week therapy was also noted in one patient.
Chromoblastomycosis: clinical and mycologic experience of 51 cases
TLDR
Overall results were 31% were cured, 57% improved and 12% failed, and the best results were obtained with cryosurgery for small lesions, with itraconazole for large ones, and in some cases the combination of both treatments.
Chromoblastomycosis – A clinical and mycological study of 71 cases from Sri Lanka
TLDR
A study of the clinical and mycological features of 71 Sri Lankan patients with chromoblastomycosis for the 16-year period from 1978 to 1993, which documents three etiological agents.
Case Report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan
TLDR
A 38‐year‐old male with history of trauma in the left gluteal region 20 years ago presented with a dark red skin eruption at the traumatized area that gradually grew to form an erythematous plaque with a well‐defined border, resulting in the diagnosis of chromoblastomycosis due to Fonsecaea pedrosoi.
Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases.
TLDR
The results suggest that the therapeutic potential of terbinafine extends well beyond its currently licensed applications to include a range of serious and life-threatening subcutaneous and systemic mycoses.
In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs.
TLDR
This work amended the macrodilution methods proposed by NCCLS and suggests that a conidial suspension free of hyphae leads to a more reliable assay and provides for better reproducibility.
...
...